ROBERT PEARLSTEIN: Open Payments
NPI 1598788689 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,653 in 72 payments from 33 companies in 2025. Trend: 2023 $2,543 · 2024 $1,506 · 2025 $1,653
Food & beverage: $1,610Education: $43
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 3 | $149 |
| Alpha Cognition USA, Inc. | 1 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| Teva Pharmaceuticals USA, Inc. | 5 | $116 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Lilly USA, LLC | 4 | $73 |
| PFIZER INC. | 4 | $66 |
| ACADIA Pharmaceuticals Inc | 4 | $62 |
| Verona Pharma, Inc. | 3 | $61 |
Products named: REXULTI, CREXONT, Zunveyl, AUSTEDO XR, INGREZZA, NUPLAZID, Ohtuvayre, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
